We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

95 hedge funds and large institutions have $1.77M invested in Ampio Pharmaceuticals Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,100% more call options, than puts

Call options by funds: $62K | Put options by funds: $1K

14% less funds holding

Funds holding: 111 → 95 (-16)

54% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 24

67% less capital invested

Capital invested by funds: $5.41M → $1.77M (-$3.64M)

75% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 20

Holders
95
Holders Change
-16
Holders Change %
-14.41%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
24
Closed
20
Calls
$62K
Puts
$1K
Net Calls
+$61K
Net Calls Change
-$131K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$194K
2
SA
Shilanski & Associates
Alaska
+$109K
3
Millennium Management
Millennium Management
New York
+$76.7K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$38K
5
Man Group
Man Group
United Kingdom
+$21.8K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$161K
2
Citadel Advisors
Citadel Advisors
Florida
-$77.4K
3
Renaissance Technologies
Renaissance Technologies
New York
-$73K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$66K
5
AAP
Arax Advisory Partners
Colorado
-$62K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCB
51
Cutter & Co Brokerage
Missouri
$2K – – –
JWA
52
JFS Wealth Advisors
Pennsylvania
$2K – – –
OC
53
Oppenheimer & Co
New York
$2K – – –
SFG
54
SNS Financial Group
Minnesota
$2K – – –
SIG
55
Stonegate Investment Group
Alabama
$2K – – –
TW
56
TrinityPoint Wealth
Connecticut
$2K – – –
MAM
57
Marotta Asset Management
Virginia
$1.45K – – –
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$1.39K -$1.4K -40 -34%
HF
59
HRT Financial
New York
$1K -$20.5K -586 -88%
PAG
60
Private Advisor Group
New Jersey
$1K -$1.3K -37 -53%
Victory Capital Management
61
Victory Capital Management
Texas
$1K -$525 -15 -16%
BCM
62
Brookstone Capital Management
Illinois
$1K -$315 -9 -13%
Commonwealth Equity Services
63
Commonwealth Equity Services
Massachusetts
$1K -$245 -7 -7%
CW
64
CreativeOne Wealth
Kansas
$1K -$245 -7 -10%
Brown Advisory
65
Brown Advisory
Maryland
$1K – – –
BSW
66
Buckingham Strategic Wealth
Missouri
$1K – – –
CWM
67
Cornerstone Wealth Management
Missouri
$1K – – –
EWA
68
Exencial Wealth Advisors
Oklahoma
$1K – – –
FIA
69
Foundations Investment Advisors
Arizona
$1K – – –
HighTower Advisors
70
HighTower Advisors
Illinois
$1K – – –
IA
71
IFG Advisory
Georgia
$1K – – –
MFA
72
Mayflower Financial Advisors
Massachusetts
$1K – – –
NFSG
73
Newbridge Financial Services Group
Florida
$1K – – –
SPC
74
Sigma Planning Corp
Michigan
$1K – – –
SFS
75
Strategic Financial Services
New York
$1K – – –
1 2
3
4 5

AMPE Hedge Fund Activity: Q3 2022 in Review

95 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2022, worth a combined $1.77M — down 67% from $5.41M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of AMPE and 5 opened new positions — a net loss of 15 holders — while 24 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, adding an estimated $194K. The largest seller was Ergoteles, exiting entirely with an estimated $161K sold.

  • 95 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2022, down from 111 in Q2 2022.
  • Funds reported $1.77M of Ampio Pharmaceuticals Inc. stock for Q3 2022, down 67% quarter-over-quarter.
  • 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2022 and 20 closed out, a net change of -15 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2022 was Vanguard Group, an estimated $194K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2022 was Ergoteles, an estimated $161K sold.

Based on aggregated 13F filings for Q3 2022.